As Senior Director of Global Access, Kelly Dannucci leads the strategy to scale access to Medicines360’s hormonal IUD across 88 low- and middle-income countries under the brand name Avibela®. She drives global partnerships and cross-functional initiatives to deliver public health impact and support development of sustainable markets for the hormonal IUD.

Since joining Medicines360 in 2015, Kelly has held various roles across operations, business development, and global access. She currently oversees global distribution strategy and supply chain operations for AVIBELA and leads the organization’s work to reduce the cost of manufacturing the hormonal IUD. Kelly manages institutional donor engagement for the Global Access program, including multimillion-dollar grant portfolios.

Kelly started her career in operations at a mental health advocacy and education nonprofit in Oakland, CA. She holds an MBA, magna cum laude, from the UC Berkeley Haas School of Business and has dual BA degrees in International Relations and French from UC Davis.

Kelly believes all women and girls around the globe should have access to the health products that best support their lives and dreams and is grateful to get to work every day to advance equitable access.